MedTrace Logo

Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia

NCT02739347 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2022-07-07

Study results available
· View outcomes & findings →

Summary

This study proposes to assess the effect of trans-cranial direct current stimulation (tDCS) on cognitive control, working memory, functional, clinical, and cognitive outcomes in schizophrenia patients.

Conditions

Interventions

DEVICE

Active Trans-cranial direct-current stimulation

Active stimulation group will receive 20 min of 2 mA direct current stimulation.

DEVICE

Sham Trans-cranial direct current stimulation

This will be an active sham involving brief (15 msec) low current (0.11 mA) pulses every 550 ms.

Sponsors & Collaborators

  • Brain & Behavior Research Foundation

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Raymond Cho, MD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-06-30
Completion
2019-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02739347 on ClinicalTrials.gov